To further confirm the association of NECL-5 with a more malignant phenotype in melanoma development, a positive correlation between NECL-5 and YY1 transcript levels has been identified by analyzing Oncomine software (r=0.468) (Figure 4a). Here, PVR is linked to melanoma.